CLSI kicks off 2019 Partnering with JT Pharma
CLSI will hold its first Partnering Day in 2019 with JT Pharma, the Pharmaceutical Division of Japan Tobacco Inc. The Partnering Day will open with an invitation-only reception in Mission Bay on March 5, followed by partnering meetings on March 6 at CLSI offices in South San Francisco.
JT Pharma has a focus on cutting-edge, innovative science and global development of orally active, small molecule therapeutics. The company is seeking partnering opportunities (i.e., research and/or development collaborations), contract research and licensing arrangements with leading academic institutions and pharma/biopharma companies to enhance internal R&D efforts. JT Pharma is looking for early-stage, first-in-class, orally active, small molecule NCEs that it can develop into therapeutics, and is also interested in novel, first-in-class drug targets.
If you are an early-stage company with novel technologies in the JT Pharma’s therapeutic or technology focus areas and would like the opportunity to meet with the JT Pharma team, please submit your application and a non-confidential Executive Summary and Deck by no later than COB January 11, 2019. (We may or may not issue a second call for applications soon thereafter.)
For more information or to submit an application, please click here.